Literature DB >> 20039319

IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort.

Martijn Verheus1, Gertraud Maskarinec, Christy G Woolcott, Christopher A Haiman, Loïc Le Marchand, Brian E Henderson, Iona Cheng, Laurence N Kolonel.   

Abstract

Insulin-like growth factor-I (IGF-I) has mitogenic properties and stimulates cell growth. In this analysis, we investigated the relation between common genetic variation in IGF1, IGFBP1, and IGFBP3, and mammographic density among 819 women of Hawaiian, European, and Japanese ancestry from the Multiethnic Cohort Study. Mammographic density was assessed using a quantitative computer-assisted method. Previously identified tag single nucleotide polymorphisms (SNPs) for IGF1 (26 tag SNPs) and IGFBP1/IGFBP3 (22 tag SNPs) were genotyped among the 819 women. Mixed models were conducted to evaluate the associations between genetic variation and mammographic density. Two SNPs were borderline statistical significantly associated with mammographic density: rs35539615 on IGFBP1 (p = 0.05) and rs2453839 on IGFBP3 (p = 0.01). Rs35767on IGF1 (p = 0.03) was also associated with mammographic density, although in opposite direction of what was expected from previous findings with IGF-I levels. The majority of SNPs were, however, not associated with mammographic density. Analyses stratified by ethnicity showed similar results as the overall analyses for IGF1 and IGFBP1. However, for 4 SNPs in the IGFBP3 gene, the minor allele was associated with lower mammographic density in Japanese Americans and higher mammographic density in Caucasians. Given the large number of SNPs tested and the few borderline significant results, we only found weak evidence that genetic variations in IGFBP1 or IGFBP3 may be related to mammographic density. Ethnicity may modify these relations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20039319      PMCID: PMC2925500          DOI: 10.1002/ijc.25142

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  27 in total

Review 1.  Mammographic density as a marker of susceptibility to breast cancer: a hypothesis.

Authors:  N F Boyd; G A Lockwood; L J Martin; J W Byng; M J Yaffe; D L Tritchler
Journal:  IARC Sci Publ       Date:  2001

Review 2.  Cellular actions of the insulin-like growth factor binding proteins.

Authors:  Sue M Firth; Robert C Baxter
Journal:  Endocr Rev       Date:  2002-12       Impact factor: 19.871

3.  Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels.

Authors:  Mattias Johansson; James D McKay; Fredrik Wiklund; Sabina Rinaldi; Martijn Verheus; Carla H van Gils; Göran Hallmans; Katarina Bälter; Hans-Olov Adami; Henrik Grönberg; Pär Stattin; Rudolf Kaaks
Journal:  J Clin Endocrinol Metab       Date:  2007-10-02       Impact factor: 5.958

4.  Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study.

Authors:  D Goodman-Gruen; E Barrett-Connor
Journal:  Am J Epidemiol       Date:  1997-06-01       Impact factor: 4.897

5.  Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.

Authors:  C Byrne; G A Colditz; W C Willett; F E Speizer; M Pollak; S E Hankinson
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

6.  Serum insulin-like growth factor-I and breast cancer.

Authors:  P Toniolo; P F Bruning; A Akhmedkhanov; J M Bonfrer; K L Koenig; A Lukanova; R E Shore; A Zeleniuch-Jacquotte
Journal:  Int J Cancer       Date:  2000-12-01       Impact factor: 7.396

7.  Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density.

Authors:  Martijn Verheus; James D McKay; Rudolf Kaaks; Federico Canzian; Carine Biessy; Mattias Johansson; Diederick E Grobbee; Petra H M Peeters; Carla H van Gils
Journal:  Breast Cancer Res Treat       Date:  2007-12-07       Impact factor: 4.872

8.  Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.

Authors:  Caroline Diorio; Jacques Brisson; Sylvie Bérubé; Michael Pollak
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04       Impact factor: 4.254

9.  The association of breast mitogens with mammographic densities.

Authors:  N F Boyd; J Stone; L J Martin; R Jong; E Fishell; M Yaffe; G Hammond; S Minkin
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640

10.  IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).

Authors:  Alpa V Patel; Iona Cheng; Federico Canzian; Loïc Le Marchand; Michael J Thun; Christine D Berg; Julie Buring; Eugenia E Calle; Stephen Chanock; Francoise Clavel-Chapelon; David G Cox; Miren Dorronsoro; Laure Dossus; Christopher A Haiman; Susan E Hankinson; Brian E Henderson; Robert Hoover; David J Hunter; Rudolf Kaaks; Laurence N Kolonel; Peter Kraft; Jakob Linseisen; Eiliv Lund; Jonas Manjer; Catherine McCarty; Petra H M Peeters; Malcolm C Pike; Michael Pollak; Elio Riboli; Daniel O Stram; Anne Tjonneland; Ruth C Travis; Dimitrios Trichopoulos; Rosario Tumino; Meredith Yeager; Regina G Ziegler; Heather Spencer Feigelson
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

View more
  9 in total

1.  Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.

Authors:  S Rinaldi; C Biessy; M Hernandez; F Lesueur; I dos-Santos-Silva; M S Rice; M Lajous; R Lopez-Ridaura; G Torres-Mejía; I Romieu
Journal:  Int J Cancer       Date:  2013-10-05       Impact factor: 7.396

2.  A genome-wide linkage study of mammographic density, a risk factor for breast cancer.

Authors:  Celia M T Greenwood; Andrew D Paterson; Linda Linton; Irene L Andrulis; Carmel Apicella; Apostolos Dimitromanolakis; Valentina Kriukov; Lisa J Martin; Ayesha Salleh; Elena Samiltchuk; Rashmi V Parekh; Melissa C Southey; Esther M John; John L Hopper; Norman F Boyd; Johanna M Rommens
Journal:  Breast Cancer Res       Date:  2011-12-21       Impact factor: 6.466

3.  Growth factor genes and change in mammographic density after stopping combined hormone therapy in the California Teachers Study.

Authors:  Eunjung Lee; Jianning Luo; Fredrick R Schumacher; David Van Den Berg; Anna H Wu; Daniel O Stram; Leslie Bernstein; Giske Ursin
Journal:  BMC Cancer       Date:  2018-11-06       Impact factor: 4.430

4.  Single nucleotide polymorphisms of insulin-like growth factor gene and mammographic breast density.

Authors:  Beata Smolarz; Luiza Wójcik; Hanna Romanowicz
Journal:  Prz Menopauzalny       Date:  2021-01-07

5.  Mammographic breast density and IGF-1 gene polymorphisms rs1520220, rs2946834 and rs6219 in Polish women.

Authors:  Beata Smolarz; Ireneusz Połać; Hanna Romanowicz
Journal:  Contemp Oncol (Pozn)       Date:  2021-10-05

6.  Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55.

Authors:  Ali Ozhand; Eunjung Lee; Anna H Wu; Merete Ellingjord-Dale; Lars A Akslen; Roberta McKean-Cowdin; Giske Ursin
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

7.  Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk.

Authors:  Joy Shi; Kristan J Aronson; Anne Grundy; Lindsay C Kobayashi; Igor Burstyn; Johanna M Schuetz; Caroline A Lohrisch; Sandip K SenGupta; Agnes S Lai; Angela Brooks-Wilson; John J Spinelli; Harriet Richardson
Journal:  Front Oncol       Date:  2016-06-08       Impact factor: 6.244

8.  Association study of IGFBP1 and IGFBP3 polymorphisms with hypertension and cardio-cerebral vascular diseases in a Chinese Han population.

Authors:  Zhengmei Fang; Song Yang; Lijun Zhu; Ying Li; Yanchun Chen; Yuelong Jin; Xianghai Zhao; Hailong Zhao; Xiaotian Chen; Yanping Zhao; Chong Shen; Yingshui Yao
Journal:  Oncotarget       Date:  2017-09-12

9.  Investigation of IGF1, IGF2BP2, and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma risk.

Authors:  Weifeng Tang; Shuchen Chen; Jun Liu; Chao Liu; Yafeng Wang; Mingqiang Kang
Journal:  J Cell Biochem       Date:  2018-10-18       Impact factor: 4.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.